FIELD: chemistry.
SUBSTANCE: described is novel biologically active compound 2-methylsulphanyl-6-nitro-7-oxo-1,2,4-triazolo[5,1-c][1,2,4]triazinide L-argininium dehydrate of formula , which has antiviral action, method of its obtaining and application for prevention and treatment of West Nile fever.
EFFECT: increased efficiency of compound application.
3 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
4-(2-HYDROXYETHOXY)METHYL)-5-METHYL-2-METHYLMERCAPTO-1,2,4-TRIAZOLO[1,5-a]PYRIMIDIN-7(4H)-ONE - SUBSTANCE HAVING ANTIVIRAL ACTION, METHOD FOR PRODUCTION AND USE THEREOF AGAINST WEST NILE FEVER AGENT | 2013 |
|
RU2537295C1 |
SODIUM SALT OF 2-ETHYLTHIO-6-NITRO-1,2,4-TRIAZOLE[5,1-c]-1,2,4-TRIAZIN-7-ONE DIHYDRATE | 2008 |
|
RU2404182C2 |
MEDICATION POSSESSING ANTI-VIRAL ACTIVITY AND CONTAINING 2-METHYLTHIO-5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-a]PYRIMIDIN-7(3H)-ON | 2007 |
|
RU2365591C2 |
2-METHYLTHIO-6-NITRO-1,2,4-TRIAZOLO[5,1-C]-1,2,4-TRIAZINE-7(4H)-ONE SODIUM SALT DIHYDRATE POSSESSING ANTIVIRAL ACTIVITY | 2005 |
|
RU2294936C1 |
3-NITRO-4-HYDROXY-7-PROPARGYLTHIO-[1,2,4]TRIAZOLO[5,1c][1,2,4]TRIAZINE AND 3-NITRO-4-HYDROXY-7-ETHYLTHIO-[1,2,4]TRIAZOLO[5,1c][1,2,4]TRIAZINE WITH ANTIVIRAL ACTIVITY | 2019 |
|
RU2775551C2 |
4-((Z)-4'-HYDROXYBUTENE-2'-YL)-2-R-6-FURYL-1,2,4-TRIAZOLO[5,1-c][1,2,4]TRIAZINE-7-ONS | 2008 |
|
RU2376307C1 |
5-METHYL-6-NITRO-7-OXO-4,7-DIHYDRO-1,2,4-TRIAZOLO[1,5-ALPHA]PYRIMIDINIDE L-ARGININIUM MONOHYDRATE | 2013 |
|
RU2529487C1 |
SODIUM SALT OF 2-n-PROPYLTHIO-6-NITRO-1,2,4-TRIAZOLE[5,1-c]-1,2,4-TRIAZIN-7-ONE DIHYDRATE AND SODIUM SALT OF 2-n-BUTYLTHIO-6-NITRO-1,2,4-TRIAZOLE[5,1-c]-1,2,4-TRIAZIN-7-ONE DIHYDRATE | 2008 |
|
RU2402552C2 |
AZOLOAZINE SALTS OF FLUOROQUINOLONES, POSSESSING ANTIBACTERIAL AND ANTIVIRAL ACTION | 2014 |
|
RU2547835C1 |
SODIUM SALT OF 2-METHYLTHIO-6-CYANO-1,2,4-TRIAZOLO[5,1-C]-1,2,4-TRIAZIN-7(4H)-ONE, TRIHYDRATE | 2015 |
|
RU2607628C1 |
Authors
Dates
2014-12-27—Published
2013-11-01—Filed